Tag: Novo Nordisk A/S

CVS to restore coverage of Zepbound, add Eli Lilly’s obesity pill to drug plans

Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking

Eli Lilly says next-generation weight loss drug clears crucial obesity trial

White House adds generic drugs to direct-to-consumer TrumpRx site

Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know

Hantavirus outbreak isn’t another Covid pandemic – but experts say it’s testing U.S. readiness

Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight

Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly’s GLP-1 dominance